SlideShare a Scribd company logo
BY GAYATRI
RESPONDING TO SYMPTOMS OF
MINOR ALINMENTS.
VIGNAN PHARMACY COLLEGE
(Approved by AICTE & PCI Affiliated to JNTU KAKINADA)
VADLAMUDI, GUNTUR DIST, ANDHRA PRADESH, INDIA, PIN: 522 213
pain
introduction
 Pain is an unpleasant ,subjective subjective
sensory and emotional experience associated
with the actual or potential tissue damage.
 As per the ameican academy of pain
medicine,pain is defined as “An unpleasant
sensation and emotional response to that
sensation
TYPES OF PAIN
 Pains are broadly classified in to
 1. Nociceptive pain.
 2. neuropathic pain.
1.NOCICEPTIVE PAIN
 Arises from the stimulation of superficial or
deep tissue receptors (nociceptors).
 E.g., pain associated with conditions like
burns, fractures of bone, appendicitis,
surgical procedures or myocardial ischemia
2.NEUROPATHIC PAIN
 Arises from a disturbance of neural pathways at any point
from the primary afferent conducting system to receptive
centers in the central nervous system(CNS).this is due to nerve
cell or axonal cell dysfunction due to compression.
 E.g., diabetic neuropathy and nerve plexus avulsion .the pain
resulted due to a primary lesion in the CNS; such pain is called
as neuropathic pain.
PATHOPHYSIOLOGY
 Damage to the tissue by mechanical ,thermal
or chemical means directly excites peripheral
nerve endings on the nerve membranes .
 This causes the release of chemical mediators
such as k+ ,and hydrogen ions , serotonin ,
bradykinin , substance p, thromboxanes,
leukotrienes, nerve growth factors and
histamines.
 Release of the inflammatory mediators
sensitives primary afferent nociceptor
neurons resulting in inflammation,pain and
sensitivity in the injured area.
 Excitation of primary afferent nociceptors
release number of neurotransmitters at the
spinsl cord synapses .
 The excitatory neurotransmitters (glutamate
and aspartate) mediate fast nociceptive
transmission bt acting at N-Methyl D-
Aspartate (NMDA)receptors
 As a result will be an increased production of
diffusible neurotransmitter nitric acid ,which acts
to increase release of glutamate ,enhancing
nociceptive transmission and contributes to
central sensitization.
 Activated phospholipase A2 enzyme increases
arachidonic acid.
 Several ascending pathways in the spinal cord
(spinothalmic,spinoreticular and
spinomesencephalic)tracts transmit nociceptive
information from the dorsal horn to the
supraspinal sites in the brain stem,thalamus and
cortex
MANAGEMENT OF PAIN
 ACUTE PAIN:-
 Non steroidal anti-inflammatory agents:-
 non steroidal anti inflammatory .Agents block the
prostaglandins produced by the arachidonic acid
cascade ,thereby decreasing the number of pain
impulses received by the CNS.
 E.g.,
 Acetyl salicyclic acid - 325-650 mg every 4 hrs.
 Paracetamol - 650 mg every 6 hrs.
 Ibuprofen - 400 mg every 8 hrs.
 Opioid agents:-
 Opioid agents include the following classes of
drugs like,
 morphine and their agonists :
morphine,hydromorphine,oxymorphine.
 Meperidine and their agonists : mepheridine and
fentanyl.
 Methadone and their agonists : methadone and
propoxyphene .
 Morphine agonists-antagonists derivatives :
pentazocine , butorphanol.
 Opioid antagonists : nalaxone.
 Central analgesics :-
 E.g., tramadol.
 CHRONIC PAIN
 Non steroidal anti inflammatory drugs
(NSAIDS) are effective for skeletal muscle.
 Methadone can be used for treating cancer
pain since it has prolonged mechanism of
action .
 Epidural clonidine is also effective for
treatment of refractory pain.Tricyclic
antidepressants and anticonvulsants are also
used for the relief of neuropathetic pain
 Non-pharmacolgical techingues
 Physical techniques considered as non
pharmacological measures include
physiotherapy,hyper stimulation
analgesia,muscle relexation, biofeedback,
nerve blocks,and surgery.
 Psychological techniques practiced to
alleviate the pain are
assertiveness,behavioral modification,
counseling, hypnosis, psychotherapy,stress
management, art and music therapy.
pyrexia
introduction
 The word pyrexia is derived from the greek
‘pyretos’ meaning ‘fire’ .
 Pyrogen is a substance that includes fever.
these can be either internal(endogenous) or
eternal(exogenous).
EXOGENOUS PYROGENS
 Exogenous pyrogens are derived from
outside the patient ;the most of them are
microbial products, microbial toxins,or whole
micro organisms
 Example of an exogenous pyrogen is the
lipopolysaccharide produced by all gram-
negative bacteria. Pyrogenic products of
gram-positive organisms include the
enterotoxins of staphylococcus aureus.
ENDOGENOUS PYROGENS
 Endogenous pyrogens are
cytokines,molecules that are a part of the
innate immune system .they are produced by
phagocytic cells.
 Example of endogenous pyrogens are
interleukin 1 (α andβ), interleukin 6(IL-6) and
tumor necrosis factor-alpha
PATHOPHYSIOLOGY
 Pyrexia is defined as a condition when the
body temperature of an individual rises above
the normal range of 36-370 c (98-1000 F),fever
is the temporary increase in the body’ s
temperature in the response to some disease
or illness.
 The body temperature can be measured by
inserting thermometer in oral cavity,
axillary,rectum and tympanic membrane of
the body.
TYPES OF FEVER
 Fever may be classified into
 Continuous fever:- if the temperature
remains above normal for long period of time
is called as continuous fever
 E.g., fever in lobar pneumonia,typhoid,and
urinary tract infection.
 Intermittent fever:- if the type of fever
where in the body temperature periodically
rises and falls
 E.g., malaria.
 Relapsing fever:- fever type that recurs
several days after the temperature has
returned to normal .
 E.g., infective endocarditis
MANAGEMENT
 Non –pharmacological methods:-
 Majority people do not require specific
treatment to cure the fever.
 In general people are advised to keep
adequately hydrated using oral rehydration
salts and water. tepid sponging is
recommended if the body temperature rises
to the level of hyperpyrexia
PREVENTION
 Fevers are commonly caused by bacteria/viral
infections.
 Good hygiene practises will reduce the risk of
developing an infection.
 Hand washing before and after meals, and after
using the wash rooms is a good practise to
prevent the infections.
 Infected people should be cared suitable to
prevent further spread of the infections and care
giving individuals are also adviced to take
suitable precautions.
Ophthalmic symptoms
introduction
 Red eye is a major sub conjuctival hemorrhage to
more severe chemical burn, most often it is called as
conjunctivitis and commonly referred as ‘pink eye’.
 common causes for conjunctivitis include
blepharitis,corneal abrasion, foreign bodies ,
keratitis, iritis, glaucoma, and scleritis.
 In addition to the redness,patients may experience
eye discharge,pain,photophobia,itching,and visual
changes.
 There are certain distinctive signs that assist in
identifying the cause of red eye.such as watering
and itching
Allergic conjunctivitis
 Alleregic conjunctivitis is usually a bilateral
condition caused by pollen or other allegins.
 In this cases where only one eye comes into
contact with the allergen,the response may
be unilateral.
 Typical symptoms of allergic conjunctivitis
include red,itchy eyes associated with tearing
and burning that gradually disappear when
the patient is no longer in proximity to the
allergin responsible.
 Most of the patients require more aggressive
therapy with selsctive histamine-1(H1)-receptor
antihistamines (e.g., levocabastine) that
relieve itching and watery eyes.
 Most of the patients require more aggressive
therapy with selsctive histamine-1(H1)-receptor
antihistamines (e.g., levocabastine) that
relieve itching and watery eyes.
 The first and second generation oral anti histamines
are effective in treating allergic conjunctivitis and
topical ophthalmic products are superior in treating
this condition .
 For rapid but short lived relief of redness, patients may
choose a topical decongestant such as naphazoline,or
oxymetazoline. these are available as single-ingredient
OTC preparation, including all clear,murine and
visine,respectively.
 If OTC medications do not provide effective relief
within 7 days or the condition.
Bacterial conjunctivitis
 Acute bacterial conjunctivitis is characterised by a copious,purulent
discharge,mild-to-moderate pain with a tingling sensation,and
diminished vision.
 Other symptoms include red eye with a foreign body sensation .
 The best diagnostic indicator is glued eye upon waking.
 Bacterial conjunctivitis can only be treated using prescription
medications therefore,patients should be referred to their physician.
Worm infections
introduction
 One of the worn infections are AMOEBIASIS.
 amoebasis is an intestinal infection caused by
a protozoa called as ENTAMOEBA
HISTOLYTICA .
 it is often spreads due to poor sanitation,
contaminatedfood drinking and drinking
water.
 the organism usally exists in two forms the
dividing forms i.e.,
 trophozoite form
 drmant form i.e.,the cyst.
 It usually begins by entering cysts by
contaminated food and water. cysts survive in
the acidic PH of the stomach and passes into the
intestine. in the ileo-cecal region,cysts undergo
excystment and each cysts gives rice to eight
trophozoites.
 The trophozoites migrate to colon for
multiplication. both trophozoites and cysts are
excreted along with the feces.
Clinical features
 In majority of the cases,infected individuals are
asymptomatic the symptoms of the infection include.
 Fever
 Abdominal discomfort and pain
 Offensive odor
 Diarrhea containing blood or mucus
 Diarrhea altering with periods of constipation or remission.
 Irregular bowel pattern.
 Ulceration of the skin (usually in the perianal region)
 Penile lesions in men after insertive anal intercourse
diagnosis
 In majority of the cases,infected individuals are
asymptomatic the symptoms of the infection include.
 Fever
 Abdominal discomfort and pain
 Offensive odor
 Diarrhea containing blood or mucus
 Diarrhea altering with periods of constipation or remission.
 Irregular bowel pattern.
 Penile lesions in men after insertive anal intercourse
 ulceration of the skin (usually in the perianal region)
Treatment
 During amoebic dysentery,electrolyte replacement and
nutritional support are essential adjunctive treatment
modalities.
 Large hepatic abscess or amoebic pericarditis may require
needle aspiration,percutaneous catheter drainage,or
rarely,surgery before drug therapy.
 The antiameobic agents are classified into two groups.they
are
 Luminal amoebicides
 e.g., iodoquinol,diloxanide furoate and
paromomycin.
 Tissue acting amoebicides
 e.g., metronidazole, tinidazole, tetracycline,
dihydroemetine, and chloroquine.
FOR INTESTINAL AND AMOEBIC LIVER
ABSES
 Metronidazole 800 mg three times a day
orally for one week is recommended
 In case if the patient is in counscious or in
emergency condition administer 500mg
metronidazole through intravenous route.
FOR AMOEBIC LIVER ABSCESS NOT RESPONDING TO
METRONIDAZOLE AND DILOXANIDE THERAPY
 Chloroquine 250 mg tablet (containing 150
mg base),2 tablets two times a day for 2 days
followed by one tablet two times a day for19
days (chloroquine 10 mg base/kg body weight
for 2 days followed by 5mg base/kg body
weight for the next 19 days) is recommended.
 The other treatment option is
dihydroemetine at a dose of 1to 1.5 mg/kg
body weight per day for 5 days.the maximum
dose of dihydroemetine per day is 90 mg.
FOR ASYMPTOMIC CYST PASSERS
 Iodoquinol is the drug of choice for the
eradication of cysts.
 For adults the dose of iodoquinol is 650 mg
three times a day for three weeks .
 For children the dose is calculated at 10
mg/kg body weight given three times a day
for 20 days.The minimum dose of iodoquinol
should not exceeds 2 grams a day.
Patient education
 About the disease
 Amoebiasis is a disease which is caused by
entamoeba histolytica a pathogen gets in to the
stomach when contaminated food or drinking water
is consumed.
 It is communicable disesase but curable.
 The commonly associated symptoms are abdominal
pain uneasiness and diarrhoea with blood and mucus
in stool.more severe illness occurs in children
(especially neonates),people who are malnourished,
patients whose immunity levels are less [ eg: AIDS,
CANCER PATIENTS]. Pregnancy and post-partum .
 About the medications
 Patient should be advised to take medications
regularly as per the docor advised. Patient
should be informed not to miss any doses or
discontinue any medications after getting a
temporary relief.
 Specific antiprotozoal agents such as
metronidazole, tinidazole, idoquinol, diloxanide
are often used to treWhen ever the patient is
using metronidazole or tinidazole inform the
patient that these medications may some time
cause taste disturbences at amoebiasis
 About life style medications
 Patient should be advised to wash hands
thoroughly with soap and running water after
using toilet and before handling food.
 Do not consume milk, cheese, or dairy
products if they are not pasteurised.
 In rural areas, people should be educated not
to pass there stools near the water bodies like
rivers or lakes.
 During travelling to the endemic areas, the
visitor should be advised to drink packed
water only.
Thank you

More Related Content

What's hot

Scope of community pharmacy
Scope of community pharmacyScope of community pharmacy
Scope of community pharmacy
Ramesh Ganpisetti
 
Community pharmacy
Community pharmacyCommunity pharmacy
Community pharmacy
MD Jahidul Islam
 
Health screening services
Health screening servicesHealth screening services
Health screening services
Arun Kumar Sanapala
 
Use of computers in hospital pharmacy, biostatistics and research methodology...
Use of computers in hospital pharmacy, biostatistics and research methodology...Use of computers in hospital pharmacy, biostatistics and research methodology...
Use of computers in hospital pharmacy, biostatistics and research methodology...
shaistasumayya2
 
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
Akram Ahmad
 
COMMUNITY PHARMACY AND MANAGEMENT – CHAPTER -1................... (1).ppt
COMMUNITY PHARMACY AND MANAGEMENT – CHAPTER -1................... (1).pptCOMMUNITY PHARMACY AND MANAGEMENT – CHAPTER -1................... (1).ppt
COMMUNITY PHARMACY AND MANAGEMENT – CHAPTER -1................... (1).ppt
Sumit Tiwari
 
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
Sarah Pulackal
 
Management of community pharmacy
Management of community pharmacyManagement of community pharmacy
Management of community pharmacy
BikashAdhikari26
 
Chapter 8_Over The Counter (OTC) Medications.pptx
Chapter 8_Over The Counter (OTC) Medications.pptxChapter 8_Over The Counter (OTC) Medications.pptx
Chapter 8_Over The Counter (OTC) Medications.pptx
VinayGaikwad14
 
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...Community pharmacy-Definition ,scope and Roles and responsibilities of commun...
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...
MerrinJoseph1
 
Staff requirments and material coding in community pharmacy
Staff requirments and material coding in community pharmacyStaff requirments and material coding in community pharmacy
Staff requirments and material coding in community pharmacy
Ramesh Ganpisetti
 
INTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACYINTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACY
Venkata subbareddy Bareddy
 
Audit community pharmacy
Audit community pharmacyAudit community pharmacy
Audit community pharmacy
Zulcaif Ahmad
 
14ab1t0022 organising structure of staff, infrastructure and workload stati...
14ab1t0022   organising structure of staff, infrastructure and workload stati...14ab1t0022   organising structure of staff, infrastructure and workload stati...
14ab1t0022 organising structure of staff, infrastructure and workload stati...
Ramesh Ganpisetti
 
Drug Therapy Monitoring
Drug Therapy MonitoringDrug Therapy Monitoring
Drug Therapy Monitoring
Dr. Ramesh Bhandari
 
Strategies to overcome barriers of patient counselling
Strategies to overcome barriers of patient counsellingStrategies to overcome barriers of patient counselling
Strategies to overcome barriers of patient counselling
Ramesh Ganpisetti
 
Introduction to clinical pharmacy
Introduction to clinical pharmacyIntroduction to clinical pharmacy
Introduction to clinical pharmacy
Dr. Ramesh Bhandari
 
Medication adherence
Medication adherenceMedication adherence
Medication adherence
KRUSHNA ZAMBARE
 
Rational use of otc medication
Rational use of otc medicationRational use of otc medication
Rational use of otc medication
Rafi Bhat
 
Community pharmacy and management
Community pharmacy and management Community pharmacy and management
Community pharmacy and management
Sumit Tiwari
 

What's hot (20)

Scope of community pharmacy
Scope of community pharmacyScope of community pharmacy
Scope of community pharmacy
 
Community pharmacy
Community pharmacyCommunity pharmacy
Community pharmacy
 
Health screening services
Health screening servicesHealth screening services
Health screening services
 
Use of computers in hospital pharmacy, biostatistics and research methodology...
Use of computers in hospital pharmacy, biostatistics and research methodology...Use of computers in hospital pharmacy, biostatistics and research methodology...
Use of computers in hospital pharmacy, biostatistics and research methodology...
 
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
 
COMMUNITY PHARMACY AND MANAGEMENT – CHAPTER -1................... (1).ppt
COMMUNITY PHARMACY AND MANAGEMENT – CHAPTER -1................... (1).pptCOMMUNITY PHARMACY AND MANAGEMENT – CHAPTER -1................... (1).ppt
COMMUNITY PHARMACY AND MANAGEMENT – CHAPTER -1................... (1).ppt
 
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
 
Management of community pharmacy
Management of community pharmacyManagement of community pharmacy
Management of community pharmacy
 
Chapter 8_Over The Counter (OTC) Medications.pptx
Chapter 8_Over The Counter (OTC) Medications.pptxChapter 8_Over The Counter (OTC) Medications.pptx
Chapter 8_Over The Counter (OTC) Medications.pptx
 
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...Community pharmacy-Definition ,scope and Roles and responsibilities of commun...
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...
 
Staff requirments and material coding in community pharmacy
Staff requirments and material coding in community pharmacyStaff requirments and material coding in community pharmacy
Staff requirments and material coding in community pharmacy
 
INTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACYINTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACY
 
Audit community pharmacy
Audit community pharmacyAudit community pharmacy
Audit community pharmacy
 
14ab1t0022 organising structure of staff, infrastructure and workload stati...
14ab1t0022   organising structure of staff, infrastructure and workload stati...14ab1t0022   organising structure of staff, infrastructure and workload stati...
14ab1t0022 organising structure of staff, infrastructure and workload stati...
 
Drug Therapy Monitoring
Drug Therapy MonitoringDrug Therapy Monitoring
Drug Therapy Monitoring
 
Strategies to overcome barriers of patient counselling
Strategies to overcome barriers of patient counsellingStrategies to overcome barriers of patient counselling
Strategies to overcome barriers of patient counselling
 
Introduction to clinical pharmacy
Introduction to clinical pharmacyIntroduction to clinical pharmacy
Introduction to clinical pharmacy
 
Medication adherence
Medication adherenceMedication adherence
Medication adherence
 
Rational use of otc medication
Rational use of otc medicationRational use of otc medication
Rational use of otc medication
 
Community pharmacy and management
Community pharmacy and management Community pharmacy and management
Community pharmacy and management
 

Similar to RESPONDING TO SYMPTOMS OF MINOR ALINMENTS.

Pain, Inflammation and Fever
Pain, Inflammation and FeverPain, Inflammation and Fever
Pain, Inflammation and Fever
FarazaJaved
 
Systemic lupus erythematosus
Systemic lupus erythematosusSystemic lupus erythematosus
Systemic lupus erythematosus
Monika Devi NR
 
Evaluation of Anti Noceceptive and Anti Inflammatory Activity of Vitis vinnif...
Evaluation of Anti Noceceptive and Anti Inflammatory Activity of Vitis vinnif...Evaluation of Anti Noceceptive and Anti Inflammatory Activity of Vitis vinnif...
Evaluation of Anti Noceceptive and Anti Inflammatory Activity of Vitis vinnif...
PrasannaSimly
 
Uveitis ppt
Uveitis pptUveitis ppt
Uveitis ppt
9021122420
 
Anaphylactic shock.domingobsn2a
Anaphylactic shock.domingobsn2aAnaphylactic shock.domingobsn2a
Anaphylactic shock.domingobsn2a
JerardLloyd
 
Herpes zoster ppt
Herpes zoster pptHerpes zoster ppt
Herpes zoster ppt
Fathimath Zahra
 
Meningitis
MeningitisMeningitis
Meningitis
keerthi samuel
 
3 lymphatic & immune system terms
3 lymphatic & immune system terms3 lymphatic & immune system terms
3 lymphatic & immune system terms
flemond
 
3 lymphatic & immune system terms
3 lymphatic & immune system terms3 lymphatic & immune system terms
3 lymphatic & immune system terms
flemond
 
3. infectious diseases
3. infectious diseases3. infectious diseases
3. infectious diseases
Akash Bhagwat
 
manangitis and seizurs for nurses made easy.pptx
manangitis and seizurs for nurses made easy.pptxmanangitis and seizurs for nurses made easy.pptx
manangitis and seizurs for nurses made easy.pptx
ajadoon84
 
PPT PHARMA 3 MITRA.pptx
PPT PHARMA 3 MITRA.pptxPPT PHARMA 3 MITRA.pptx
PPT PHARMA 3 MITRA.pptx
PramodKumarYadav48
 
POISONING
POISONINGPOISONING
POISONING
Koyel Thander
 
manangitis and seizurs for nurses in health care.pptx
manangitis and seizurs for nurses in health care.pptxmanangitis and seizurs for nurses in health care.pptx
manangitis and seizurs for nurses in health care.pptx
ajadoon84
 
microbial disease of CNS.pdf and others for
microbial disease of CNS.pdf and others formicrobial disease of CNS.pdf and others for
microbial disease of CNS.pdf and others for
EltonJohnDelosSantos
 
Cns Infxs
Cns InfxsCns Infxs
Cns Infxs
mycomic
 
Brain Infxn 71609
Brain Infxn 71609Brain Infxn 71609
Brain Infxn 71609
mycomic
 
Drug induced dermal disorders ppt by Salva Safdar
Drug induced dermal disorders ppt by Salva SafdarDrug induced dermal disorders ppt by Salva Safdar
Drug induced dermal disorders ppt by Salva Safdar
PARUL UNIVERSITY
 
Types of hypersensitivity reactions/ dental crown & bridge courses
Types of hypersensitivity reactions/ dental crown & bridge coursesTypes of hypersensitivity reactions/ dental crown & bridge courses
Types of hypersensitivity reactions/ dental crown & bridge courses
Indian dental academy
 
Uveitis
UveitisUveitis
Uveitis
Amr Mounir
 

Similar to RESPONDING TO SYMPTOMS OF MINOR ALINMENTS. (20)

Pain, Inflammation and Fever
Pain, Inflammation and FeverPain, Inflammation and Fever
Pain, Inflammation and Fever
 
Systemic lupus erythematosus
Systemic lupus erythematosusSystemic lupus erythematosus
Systemic lupus erythematosus
 
Evaluation of Anti Noceceptive and Anti Inflammatory Activity of Vitis vinnif...
Evaluation of Anti Noceceptive and Anti Inflammatory Activity of Vitis vinnif...Evaluation of Anti Noceceptive and Anti Inflammatory Activity of Vitis vinnif...
Evaluation of Anti Noceceptive and Anti Inflammatory Activity of Vitis vinnif...
 
Uveitis ppt
Uveitis pptUveitis ppt
Uveitis ppt
 
Anaphylactic shock.domingobsn2a
Anaphylactic shock.domingobsn2aAnaphylactic shock.domingobsn2a
Anaphylactic shock.domingobsn2a
 
Herpes zoster ppt
Herpes zoster pptHerpes zoster ppt
Herpes zoster ppt
 
Meningitis
MeningitisMeningitis
Meningitis
 
3 lymphatic & immune system terms
3 lymphatic & immune system terms3 lymphatic & immune system terms
3 lymphatic & immune system terms
 
3 lymphatic & immune system terms
3 lymphatic & immune system terms3 lymphatic & immune system terms
3 lymphatic & immune system terms
 
3. infectious diseases
3. infectious diseases3. infectious diseases
3. infectious diseases
 
manangitis and seizurs for nurses made easy.pptx
manangitis and seizurs for nurses made easy.pptxmanangitis and seizurs for nurses made easy.pptx
manangitis and seizurs for nurses made easy.pptx
 
PPT PHARMA 3 MITRA.pptx
PPT PHARMA 3 MITRA.pptxPPT PHARMA 3 MITRA.pptx
PPT PHARMA 3 MITRA.pptx
 
POISONING
POISONINGPOISONING
POISONING
 
manangitis and seizurs for nurses in health care.pptx
manangitis and seizurs for nurses in health care.pptxmanangitis and seizurs for nurses in health care.pptx
manangitis and seizurs for nurses in health care.pptx
 
microbial disease of CNS.pdf and others for
microbial disease of CNS.pdf and others formicrobial disease of CNS.pdf and others for
microbial disease of CNS.pdf and others for
 
Cns Infxs
Cns InfxsCns Infxs
Cns Infxs
 
Brain Infxn 71609
Brain Infxn 71609Brain Infxn 71609
Brain Infxn 71609
 
Drug induced dermal disorders ppt by Salva Safdar
Drug induced dermal disorders ppt by Salva SafdarDrug induced dermal disorders ppt by Salva Safdar
Drug induced dermal disorders ppt by Salva Safdar
 
Types of hypersensitivity reactions/ dental crown & bridge courses
Types of hypersensitivity reactions/ dental crown & bridge coursesTypes of hypersensitivity reactions/ dental crown & bridge courses
Types of hypersensitivity reactions/ dental crown & bridge courses
 
Uveitis
UveitisUveitis
Uveitis
 

More from Ramesh Ganpisetti

PHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEEPHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEE
Ramesh Ganpisetti
 
A. SUJATHA
A. SUJATHAA. SUJATHA
A. SUJATHA
Ramesh Ganpisetti
 
VELAVARTHIPATI PRUDHVI SAI
VELAVARTHIPATI PRUDHVI SAIVELAVARTHIPATI PRUDHVI SAI
VELAVARTHIPATI PRUDHVI SAI
Ramesh Ganpisetti
 
UNNAM VENKATESWARLU
UNNAM VENKATESWARLUUNNAM VENKATESWARLU
UNNAM VENKATESWARLU
Ramesh Ganpisetti
 
HARSHINI SAIDU
HARSHINI SAIDUHARSHINI SAIDU
HARSHINI SAIDU
Ramesh Ganpisetti
 
RAGAM SWETHA SAMRAJYAM
RAGAM SWETHA SAMRAJYAMRAGAM SWETHA SAMRAJYAM
RAGAM SWETHA SAMRAJYAM
Ramesh Ganpisetti
 
P. MERIKUMARI
P. MERIKUMARIP. MERIKUMARI
P. MERIKUMARI
Ramesh Ganpisetti
 
NARISETTI SINDURA
NARISETTI SINDURANARISETTI SINDURA
NARISETTI SINDURA
Ramesh Ganpisetti
 
M. SRUJANA
M. SRUJANAM. SRUJANA
M. SRUJANA
Ramesh Ganpisetti
 
kamma sri pandu mukharjee
kamma sri pandu mukharjeekamma sri pandu mukharjee
kamma sri pandu mukharjee
Ramesh Ganpisetti
 
J. SUBRAHMANYAM
J. SUBRAHMANYAMJ. SUBRAHMANYAM
J. SUBRAHMANYAM
Ramesh Ganpisetti
 
KHANDEKER FATIMA FARAH HASSAN
KHANDEKER FATIMA FARAH HASSANKHANDEKER FATIMA FARAH HASSAN
KHANDEKER FATIMA FARAH HASSAN
Ramesh Ganpisetti
 
DASARI NIROOSHA
DASARI NIROOSHADASARI NIROOSHA
DASARI NIROOSHA
Ramesh Ganpisetti
 
KOTHA BHUVANESWARI
KOTHA BHUVANESWARIKOTHA BHUVANESWARI
KOTHA BHUVANESWARI
Ramesh Ganpisetti
 
V. SIVANI
V. SIVANIV. SIVANI
R. SAI YAMINI
R. SAI YAMINIR. SAI YAMINI
R. SAI YAMINI
Ramesh Ganpisetti
 
INDU
INDUINDU
DINDI.SANDHYA RANI
DINDI.SANDHYA RANIDINDI.SANDHYA RANI
DINDI.SANDHYA RANI
Ramesh Ganpisetti
 
A.sai sivani
A.sai sivaniA.sai sivani
A.sai sivani
Ramesh Ganpisetti
 
V. RAGINI
V. RAGINIV. RAGINI

More from Ramesh Ganpisetti (20)

PHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEEPHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEE
 
A. SUJATHA
A. SUJATHAA. SUJATHA
A. SUJATHA
 
VELAVARTHIPATI PRUDHVI SAI
VELAVARTHIPATI PRUDHVI SAIVELAVARTHIPATI PRUDHVI SAI
VELAVARTHIPATI PRUDHVI SAI
 
UNNAM VENKATESWARLU
UNNAM VENKATESWARLUUNNAM VENKATESWARLU
UNNAM VENKATESWARLU
 
HARSHINI SAIDU
HARSHINI SAIDUHARSHINI SAIDU
HARSHINI SAIDU
 
RAGAM SWETHA SAMRAJYAM
RAGAM SWETHA SAMRAJYAMRAGAM SWETHA SAMRAJYAM
RAGAM SWETHA SAMRAJYAM
 
P. MERIKUMARI
P. MERIKUMARIP. MERIKUMARI
P. MERIKUMARI
 
NARISETTI SINDURA
NARISETTI SINDURANARISETTI SINDURA
NARISETTI SINDURA
 
M. SRUJANA
M. SRUJANAM. SRUJANA
M. SRUJANA
 
kamma sri pandu mukharjee
kamma sri pandu mukharjeekamma sri pandu mukharjee
kamma sri pandu mukharjee
 
J. SUBRAHMANYAM
J. SUBRAHMANYAMJ. SUBRAHMANYAM
J. SUBRAHMANYAM
 
KHANDEKER FATIMA FARAH HASSAN
KHANDEKER FATIMA FARAH HASSANKHANDEKER FATIMA FARAH HASSAN
KHANDEKER FATIMA FARAH HASSAN
 
DASARI NIROOSHA
DASARI NIROOSHADASARI NIROOSHA
DASARI NIROOSHA
 
KOTHA BHUVANESWARI
KOTHA BHUVANESWARIKOTHA BHUVANESWARI
KOTHA BHUVANESWARI
 
V. SIVANI
V. SIVANIV. SIVANI
V. SIVANI
 
R. SAI YAMINI
R. SAI YAMINIR. SAI YAMINI
R. SAI YAMINI
 
INDU
INDUINDU
INDU
 
DINDI.SANDHYA RANI
DINDI.SANDHYA RANIDINDI.SANDHYA RANI
DINDI.SANDHYA RANI
 
A.sai sivani
A.sai sivaniA.sai sivani
A.sai sivani
 
V. RAGINI
V. RAGINIV. RAGINI
V. RAGINI
 

Recently uploaded

Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
ayushrajshrivastava7
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
phuakl
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
DrGirishJHoogar
 
SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
KULDEEP VYAS
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1 Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1
Jyoti Bhaghasra
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Rahul Sen
 
5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods
Dr. Deepika's Homeopathy - Gaur City
 
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
Université de Montréal
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
Dr. Dhwani kawedia
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
PARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptxPARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptx
MwambaChikonde1
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
13. PROM premature rupture of membranes
13.  PROM premature rupture of membranes13.  PROM premature rupture of membranes
13. PROM premature rupture of membranes
TigistuMelak
 

Recently uploaded (20)

Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
 
SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1 Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
 
5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods
 
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
PARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptxPARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptx
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
13. PROM premature rupture of membranes
13.  PROM premature rupture of membranes13.  PROM premature rupture of membranes
13. PROM premature rupture of membranes
 

RESPONDING TO SYMPTOMS OF MINOR ALINMENTS.

  • 1. BY GAYATRI RESPONDING TO SYMPTOMS OF MINOR ALINMENTS. VIGNAN PHARMACY COLLEGE (Approved by AICTE & PCI Affiliated to JNTU KAKINADA) VADLAMUDI, GUNTUR DIST, ANDHRA PRADESH, INDIA, PIN: 522 213
  • 3. introduction  Pain is an unpleasant ,subjective subjective sensory and emotional experience associated with the actual or potential tissue damage.  As per the ameican academy of pain medicine,pain is defined as “An unpleasant sensation and emotional response to that sensation
  • 4. TYPES OF PAIN  Pains are broadly classified in to  1. Nociceptive pain.  2. neuropathic pain.
  • 5. 1.NOCICEPTIVE PAIN  Arises from the stimulation of superficial or deep tissue receptors (nociceptors).  E.g., pain associated with conditions like burns, fractures of bone, appendicitis, surgical procedures or myocardial ischemia
  • 6. 2.NEUROPATHIC PAIN  Arises from a disturbance of neural pathways at any point from the primary afferent conducting system to receptive centers in the central nervous system(CNS).this is due to nerve cell or axonal cell dysfunction due to compression.  E.g., diabetic neuropathy and nerve plexus avulsion .the pain resulted due to a primary lesion in the CNS; such pain is called as neuropathic pain.
  • 7. PATHOPHYSIOLOGY  Damage to the tissue by mechanical ,thermal or chemical means directly excites peripheral nerve endings on the nerve membranes .  This causes the release of chemical mediators such as k+ ,and hydrogen ions , serotonin , bradykinin , substance p, thromboxanes, leukotrienes, nerve growth factors and histamines.
  • 8.  Release of the inflammatory mediators sensitives primary afferent nociceptor neurons resulting in inflammation,pain and sensitivity in the injured area.  Excitation of primary afferent nociceptors release number of neurotransmitters at the spinsl cord synapses .  The excitatory neurotransmitters (glutamate and aspartate) mediate fast nociceptive transmission bt acting at N-Methyl D- Aspartate (NMDA)receptors
  • 9.  As a result will be an increased production of diffusible neurotransmitter nitric acid ,which acts to increase release of glutamate ,enhancing nociceptive transmission and contributes to central sensitization.  Activated phospholipase A2 enzyme increases arachidonic acid.  Several ascending pathways in the spinal cord (spinothalmic,spinoreticular and spinomesencephalic)tracts transmit nociceptive information from the dorsal horn to the supraspinal sites in the brain stem,thalamus and cortex
  • 10. MANAGEMENT OF PAIN  ACUTE PAIN:-  Non steroidal anti-inflammatory agents:-  non steroidal anti inflammatory .Agents block the prostaglandins produced by the arachidonic acid cascade ,thereby decreasing the number of pain impulses received by the CNS.  E.g.,  Acetyl salicyclic acid - 325-650 mg every 4 hrs.  Paracetamol - 650 mg every 6 hrs.  Ibuprofen - 400 mg every 8 hrs.
  • 11.  Opioid agents:-  Opioid agents include the following classes of drugs like,  morphine and their agonists : morphine,hydromorphine,oxymorphine.  Meperidine and their agonists : mepheridine and fentanyl.  Methadone and their agonists : methadone and propoxyphene .  Morphine agonists-antagonists derivatives : pentazocine , butorphanol.  Opioid antagonists : nalaxone.
  • 12.  Central analgesics :-  E.g., tramadol.
  • 13.  CHRONIC PAIN  Non steroidal anti inflammatory drugs (NSAIDS) are effective for skeletal muscle.  Methadone can be used for treating cancer pain since it has prolonged mechanism of action .  Epidural clonidine is also effective for treatment of refractory pain.Tricyclic antidepressants and anticonvulsants are also used for the relief of neuropathetic pain
  • 14.  Non-pharmacolgical techingues  Physical techniques considered as non pharmacological measures include physiotherapy,hyper stimulation analgesia,muscle relexation, biofeedback, nerve blocks,and surgery.  Psychological techniques practiced to alleviate the pain are assertiveness,behavioral modification, counseling, hypnosis, psychotherapy,stress management, art and music therapy.
  • 16. introduction  The word pyrexia is derived from the greek ‘pyretos’ meaning ‘fire’ .  Pyrogen is a substance that includes fever. these can be either internal(endogenous) or eternal(exogenous).
  • 17. EXOGENOUS PYROGENS  Exogenous pyrogens are derived from outside the patient ;the most of them are microbial products, microbial toxins,or whole micro organisms  Example of an exogenous pyrogen is the lipopolysaccharide produced by all gram- negative bacteria. Pyrogenic products of gram-positive organisms include the enterotoxins of staphylococcus aureus.
  • 18. ENDOGENOUS PYROGENS  Endogenous pyrogens are cytokines,molecules that are a part of the innate immune system .they are produced by phagocytic cells.  Example of endogenous pyrogens are interleukin 1 (α andβ), interleukin 6(IL-6) and tumor necrosis factor-alpha
  • 19. PATHOPHYSIOLOGY  Pyrexia is defined as a condition when the body temperature of an individual rises above the normal range of 36-370 c (98-1000 F),fever is the temporary increase in the body’ s temperature in the response to some disease or illness.  The body temperature can be measured by inserting thermometer in oral cavity, axillary,rectum and tympanic membrane of the body.
  • 20. TYPES OF FEVER  Fever may be classified into  Continuous fever:- if the temperature remains above normal for long period of time is called as continuous fever  E.g., fever in lobar pneumonia,typhoid,and urinary tract infection.  Intermittent fever:- if the type of fever where in the body temperature periodically rises and falls  E.g., malaria.
  • 21.  Relapsing fever:- fever type that recurs several days after the temperature has returned to normal .  E.g., infective endocarditis
  • 22. MANAGEMENT  Non –pharmacological methods:-  Majority people do not require specific treatment to cure the fever.  In general people are advised to keep adequately hydrated using oral rehydration salts and water. tepid sponging is recommended if the body temperature rises to the level of hyperpyrexia
  • 23. PREVENTION  Fevers are commonly caused by bacteria/viral infections.  Good hygiene practises will reduce the risk of developing an infection.  Hand washing before and after meals, and after using the wash rooms is a good practise to prevent the infections.  Infected people should be cared suitable to prevent further spread of the infections and care giving individuals are also adviced to take suitable precautions.
  • 25. introduction  Red eye is a major sub conjuctival hemorrhage to more severe chemical burn, most often it is called as conjunctivitis and commonly referred as ‘pink eye’.  common causes for conjunctivitis include blepharitis,corneal abrasion, foreign bodies , keratitis, iritis, glaucoma, and scleritis.  In addition to the redness,patients may experience eye discharge,pain,photophobia,itching,and visual changes.  There are certain distinctive signs that assist in identifying the cause of red eye.such as watering and itching
  • 26. Allergic conjunctivitis  Alleregic conjunctivitis is usually a bilateral condition caused by pollen or other allegins.  In this cases where only one eye comes into contact with the allergen,the response may be unilateral.  Typical symptoms of allergic conjunctivitis include red,itchy eyes associated with tearing and burning that gradually disappear when the patient is no longer in proximity to the allergin responsible.
  • 27.  Most of the patients require more aggressive therapy with selsctive histamine-1(H1)-receptor antihistamines (e.g., levocabastine) that relieve itching and watery eyes.  Most of the patients require more aggressive therapy with selsctive histamine-1(H1)-receptor antihistamines (e.g., levocabastine) that relieve itching and watery eyes.
  • 28.  The first and second generation oral anti histamines are effective in treating allergic conjunctivitis and topical ophthalmic products are superior in treating this condition .  For rapid but short lived relief of redness, patients may choose a topical decongestant such as naphazoline,or oxymetazoline. these are available as single-ingredient OTC preparation, including all clear,murine and visine,respectively.  If OTC medications do not provide effective relief within 7 days or the condition.
  • 29. Bacterial conjunctivitis  Acute bacterial conjunctivitis is characterised by a copious,purulent discharge,mild-to-moderate pain with a tingling sensation,and diminished vision.  Other symptoms include red eye with a foreign body sensation .  The best diagnostic indicator is glued eye upon waking.  Bacterial conjunctivitis can only be treated using prescription medications therefore,patients should be referred to their physician.
  • 31. introduction  One of the worn infections are AMOEBIASIS.  amoebasis is an intestinal infection caused by a protozoa called as ENTAMOEBA HISTOLYTICA .  it is often spreads due to poor sanitation, contaminatedfood drinking and drinking water.
  • 32.  the organism usally exists in two forms the dividing forms i.e.,  trophozoite form  drmant form i.e.,the cyst.  It usually begins by entering cysts by contaminated food and water. cysts survive in the acidic PH of the stomach and passes into the intestine. in the ileo-cecal region,cysts undergo excystment and each cysts gives rice to eight trophozoites.  The trophozoites migrate to colon for multiplication. both trophozoites and cysts are excreted along with the feces.
  • 33. Clinical features  In majority of the cases,infected individuals are asymptomatic the symptoms of the infection include.  Fever  Abdominal discomfort and pain  Offensive odor  Diarrhea containing blood or mucus  Diarrhea altering with periods of constipation or remission.  Irregular bowel pattern.  Ulceration of the skin (usually in the perianal region)  Penile lesions in men after insertive anal intercourse
  • 34. diagnosis  In majority of the cases,infected individuals are asymptomatic the symptoms of the infection include.  Fever  Abdominal discomfort and pain  Offensive odor  Diarrhea containing blood or mucus  Diarrhea altering with periods of constipation or remission.  Irregular bowel pattern.  Penile lesions in men after insertive anal intercourse  ulceration of the skin (usually in the perianal region)
  • 35. Treatment  During amoebic dysentery,electrolyte replacement and nutritional support are essential adjunctive treatment modalities.  Large hepatic abscess or amoebic pericarditis may require needle aspiration,percutaneous catheter drainage,or rarely,surgery before drug therapy.  The antiameobic agents are classified into two groups.they are  Luminal amoebicides  e.g., iodoquinol,diloxanide furoate and paromomycin.  Tissue acting amoebicides  e.g., metronidazole, tinidazole, tetracycline, dihydroemetine, and chloroquine.
  • 36. FOR INTESTINAL AND AMOEBIC LIVER ABSES  Metronidazole 800 mg three times a day orally for one week is recommended  In case if the patient is in counscious or in emergency condition administer 500mg metronidazole through intravenous route.
  • 37. FOR AMOEBIC LIVER ABSCESS NOT RESPONDING TO METRONIDAZOLE AND DILOXANIDE THERAPY  Chloroquine 250 mg tablet (containing 150 mg base),2 tablets two times a day for 2 days followed by one tablet two times a day for19 days (chloroquine 10 mg base/kg body weight for 2 days followed by 5mg base/kg body weight for the next 19 days) is recommended.  The other treatment option is dihydroemetine at a dose of 1to 1.5 mg/kg body weight per day for 5 days.the maximum dose of dihydroemetine per day is 90 mg.
  • 38. FOR ASYMPTOMIC CYST PASSERS  Iodoquinol is the drug of choice for the eradication of cysts.  For adults the dose of iodoquinol is 650 mg three times a day for three weeks .  For children the dose is calculated at 10 mg/kg body weight given three times a day for 20 days.The minimum dose of iodoquinol should not exceeds 2 grams a day.
  • 39. Patient education  About the disease  Amoebiasis is a disease which is caused by entamoeba histolytica a pathogen gets in to the stomach when contaminated food or drinking water is consumed.  It is communicable disesase but curable.  The commonly associated symptoms are abdominal pain uneasiness and diarrhoea with blood and mucus in stool.more severe illness occurs in children (especially neonates),people who are malnourished, patients whose immunity levels are less [ eg: AIDS, CANCER PATIENTS]. Pregnancy and post-partum .
  • 40.  About the medications  Patient should be advised to take medications regularly as per the docor advised. Patient should be informed not to miss any doses or discontinue any medications after getting a temporary relief.  Specific antiprotozoal agents such as metronidazole, tinidazole, idoquinol, diloxanide are often used to treWhen ever the patient is using metronidazole or tinidazole inform the patient that these medications may some time cause taste disturbences at amoebiasis
  • 41.  About life style medications  Patient should be advised to wash hands thoroughly with soap and running water after using toilet and before handling food.  Do not consume milk, cheese, or dairy products if they are not pasteurised.  In rural areas, people should be educated not to pass there stools near the water bodies like rivers or lakes.  During travelling to the endemic areas, the visitor should be advised to drink packed water only.